SINEMET CR 521 (Sinemet CR 50 mg / 200 mg)
Generic Name: carbidopa/levodopa
Pill imprint SINEMET CR 521 has been identified as Sinemet CR 50 mg / 200 mg.
Sinemet CR is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Sinemet CR 50 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- carbidopa/levodopa
- Imprint:
- SINEMET CR 521
- Strength:
- 50 mg / 200 mg
- Color:
- Peach
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00056-0521
- Inactive Ingredients:
- hydroxypropyl cellulose
magnesium stearate
ferric oxide red
D&C Yellow No. 10
More about Sinemet CR (carbidopa / levodopa)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
